ProShares Ultra Nasdaq Biotechnology (BIB) Leverage/Terbalik
$109,80
▼ -0,67 (-0,61%)
Perubahan 1 hari
$62,04 – $126,40
Rentang 52 minggu
Data kepemilikan belum tersedia untuk dana ini.
BIB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 2 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -9,84% | ▼ -9,78% |
| 3M | ▲ +2,77% | ▲ +2,84% |
| 6M | ▲ +34,28% | ▲ +34,37% |
| YTD | ▲ +37,63% | ▲ +37,74% |
| 1Y | ▲ +73,21% | ▲ +73,64% |
| 3Y | ▲ +135,47% | ▲ +142,03% |
| 5Y | ▲ +20,16% | ▲ +23,54% |
| Maks | ▲ +1362,31% | ▲ +1406,10% |
Volatilitas 1T42,75%
Volatilitas 3Y41,86%
Penurunan Maksimum 3Y
-45,99%
Beta 3Y0,85
Sharpe 1Y*1,50
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Bulan lalu (Mei 2026)
-$4.8M
Kuartal berakhir Mei 2026
-$13.9M
12 bulan terakhir
-$12.0M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 267 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | 45256X103 | $286K | 0,39 | 38.008 | EC | US |
| Vaxcyte, Inc. | 92243G108 | $273K | 0,37 | 5.321 | EC | US |
| Alkermes plc | · | $260K | 0,35 | 6.163 | EC | IE |
| Immunovant, Inc. | 45258J102 | $251K | 0,34 | 7.523 | EC | US |
| Kymera Therapeutics, Inc. | 501575104 | $246K | 0,33 | 3.017 | EC | US |
| Protagonist Therapeutics, Inc. | 74366E102 | $235K | 0,32 | 2.361 | EC | US |
| Mirum Pharmaceuticals, Inc. | 604749101 | $226K | 0,31 | 2.231 | EC | US |
| PTC Therapeutics, Inc. | 69366J200 | $226K | 0,31 | 3.062 | EC | US |
| Rhythm Pharmaceuticals, Inc. | 76243J105 | $223K | 0,30 | 2.526 | EC | US |
| Spyre Therapeutics, Inc. | 00773J202 | $214K | 0,29 | 2.905 | EC | US |
| Cogent Biosciences, Inc. | 19240Q201 | $210K | 0,28 | 6.002 | EC | US |
| CRISPR Therapeutics AG | · | $199K | 0,27 | 3.550 | EC | CH |
| CG oncology, Inc. | 156944100 | $195K | 0,26 | 3.123 | EC | US |
| Scholar Rock Holding Corp. | 80706P103 | $186K | 0,25 | 3.773 | EC | US |
| Centessa Pharmaceuticals plc | 152309100 | $176K | 0,24 | 4.423 | EC | GB |
| Caris Life Sciences, Inc. | 142152107 | $174K | 0,24 | 10.431 | EC | US |
| Ligand Pharmaceuticals, Inc. | 53220K504 | $171K | 0,23 | 736 | EC | US |
| Xenon Pharmaceuticals, Inc. | 98420N105 | $168K | 0,23 | 3.074 | EC | CA |
| Apogee Therapeutics, Inc. | 03770N101 | $167K | 0,23 | 2.028 | EC | US |
| Indivior Pharmaceuticals, Inc. | 45579U109 | $167K | 0,23 | 4.624 | EC | US |
| Travere Therapeutics, Inc. | 89422G107 | $161K | 0,22 | 3.409 | EC | US |
| Amneal Pharmaceuticals, Inc. | 03168L105 | $153K | 0,21 | 11.632 | EC | US |
| Twist Bioscience Corp. | 90184D100 | $152K | 0,21 | 2.266 | EC | US |
| Erasca, Inc. | 29479A108 | $147K | 0,20 | 11.444 | EC | US |
| Newamsterdam Pharma Co. NV | · | $143K | 0,19 | 4.252 | EC | NL |
| Crinetics Pharmaceuticals, Inc. | 22663K107 | $138K | 0,19 | 3.872 | EC | US |
| ACADIA Pharmaceuticals, Inc. | 004225108 | $137K | 0,19 | 6.303 | EC | US |
| Veracyte, Inc. | 92337F107 | $136K | 0,18 | 2.938 | EC | US |
| Edgewise Therapeutics, Inc. | 28036F105 | $135K | 0,18 | 3.966 | EC | US |
| Beam Therapeutics, Inc. | 07373V105 | $124K | 0,17 | 3.767 | EC | US |
| Denali Therapeutics, Inc. | 24823R105 | $123K | 0,17 | 5.863 | EC | US |
| 10X Genomics, Inc. | 88025U109 | $123K | 0,17 | 4.351 | EC | US |
| Dyne Therapeutics, Inc. | 26818M108 | $118K | 0,16 | 6.087 | EC | US |
| Structure Therapeutics, Inc. | 86366E106 | $113K | 0,15 | 2.880 | EC | KY |
| Tango Therapeutics, Inc. | 87583X109 | $109K | 0,15 | 4.978 | EC | US |
| Oruka Therapeutics, Inc. | 687604108 | $105K | 0,14 | 1.789 | EC | US |
| GRAIL, Inc. | 384747101 | $103K | 0,14 | 1.439 | EC | US |
| Alumis, Inc. | 022307102 | $101K | 0,14 | 4.674 | EC | US |
| Arcutis Biotherapeutics, Inc. | 03969K108 | $98K | 0,13 | 4.587 | EC | US |
| Disc Medicine, Inc. | 254604101 | $98K | 0,13 | 1.411 | EC | US |
| Supernus Pharmaceuticals, Inc. | 868459108 | $98K | 0,13 | 2.120 | EC | US |
| Ideaya Biosciences, Inc. | 45166A102 | $96K | 0,13 | 3.246 | EC | US |
| Vera Therapeutics, Inc. | 92337R101 | $94K | 0,13 | 2.636 | EC | US |
| Tarsus Pharmaceuticals, Inc. | 87650L103 | $93K | 0,13 | 1.573 | EC | US |
| Relay Therapeutics, Inc. | 75943R102 | $93K | 0,13 | 6.606 | EC | US |
| Mineralys Therapeutics, Inc. | 603170101 | $92K | 0,13 | 2.925 | EC | US |
| Definium Therapeutics, Inc. | 24477V105 | $89K | 0,12 | 3.685 | EC | CA |
| Enliven Therapeutics, Inc. | 29337E102 | $87K | 0,12 | 2.196 | EC | US |
| Adaptive Biotechnologies Corp. | 00650F109 | $86K | 0,12 | 5.692 | EC | US |
| Ultragenyx Pharmaceutical, Inc. | 90400D108 | $85K | 0,12 | 3.571 | EC | US |
Dividen 13 pembayaran
0,20%Imbal hasil TTM
$0,23Pembayaran TTM / saham
Kuartalan
(est.)
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 23 Sep. 2026 | $0,0830 |
| 25 Maret 2026 | $0,0070 |
| 24 Des. 2025 | $0,1350 |
| 24 Sep. 2025 | $0,1810 |
| 25 Juni 2025 | $0,1710 |
| 26 Maret 2025 | $0,1310 |
| 23 Des. 2024 | $0,3960 |
| 25 Sep. 2024 | $0,1530 |
| 26 Juni 2024 | $0,2650 |
| 20 Maret 2024 | $0,0400 |
| 20 Des. 2023 | $0,0380 |
| 22 Des. 2022 | $0,0200 |
| 21 Sep. 2010 | $0,0110 |
Pemilik institusional (13F) 22 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785.973 | 21,94% | 7.802 | Saham | 30 Juni 2026 |
| Capital Investment Advisors, LLC | $599.013 | 16,72% | 5.946 | Saham | 30 Juni 2026 |
| Kaizen Financial Strategies | $535.554 | 14,95% | 5.315 | Saham | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413.034 | 11,53% | 4.100 | Opsi beli | 30 Juni 2026 |
| Palumbo Wealth Management LLC | $402.960 | 11,25% | 4.000 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $302.220 | 8,44% | 3.000 | Opsi beli | 30 Juni 2026 |
| Jump Financial, LLC | $257.189 | 7,18% | 2.553 | Saham | 30 Juni 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102.957 | 2,87% | 1.022 | Saham | 30 Juni 2026 |
| FRANKLIN RESOURCES INC | $70.115 | 1,96% | 696 | Saham | 30 Juni 2026 |
| PNC Financial Services Group, Inc. | $50.370 | 1,41% | 500 | Saham | 30 Juni 2026 |
| Ashton Thomas Private Wealth, LLC | $37.576 | 1,05% | 373 | Saham | 30 Juni 2026 |
| Truvestments Capital LLC | $12.593 | 0,35% | 125 | Saham | 30 Juni 2026 |
| Axiom Investment Management LLC | $5.037 | 0,14% | 50 | Saham | 30 Juni 2026 |
| Qube Research & Technologies Ltd | $4.936 | 0,14% | 49 | Saham | 30 Juni 2026 |
| SIMPLEX TRADING, LLC | $1.309 | 0,04% | 13 | Saham | 30 Juni 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0,01% | 2.400 | Saham | 30 Juni 2026 |
| Rockefeller Capital Management L.P. | $201 | 0,01% | 2 | Saham | 30 Juni 2026 |
| MORGAN STANLEY | $131 | 0,00% | 1 | Saham | 30 Juni 2026 |
| UBS Group AG | $101 | 0,00% | 1 | Saham | 30 Juni 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0,00% | 1 | Saham | 30 Juni 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0,00% | 198 | Saham | 30 Juni 2026 |
| ROYAL BANK OF CANADA | $0 | 0,00% | 1 | Saham | 30 Juni 2026 |